Showing posts with label 2-diphenyl-3-furanmethanamine hydrochloride) is a σ1 agonist. Show all posts
Showing posts with label 2-diphenyl-3-furanmethanamine hydrochloride) is a σ1 agonist. Show all posts
Tuesday, January 5, 2016

Anavex reports safety and efficacy data of ANAVEX 2-73 Phase 2a trial in Alzheimer’s patients

›
ANAVEX 2-73 (Tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride) is a σ1 agonist (IC50 = 860 nM); also displays a...